Pharma Equity Group A/S (OCSE:PEG) EV-to-Revenue : (As of Jun. 13, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pharma Equity Group A/S's enterprise value is kr305.02 Mil. Pharma Equity Group A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil. Therefore, Pharma Equity Group A/S's EV-to-Revenue for today is .

The historical rank and industry rank for Pharma Equity Group A/S's EV-to-Revenue or its related term are showing as below:

During the past 13 years, the highest EV-to-Revenue of Pharma Equity Group A/S was 59.21. The lowest was 25.28. And the median was 54.63.

OCSE:PEG's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.93
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-13), Pharma Equity Group A/S's stock price is kr0.262. Pharma Equity Group A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00. Therefore, Pharma Equity Group A/S's PS Ratio for today is .

Pharma Equity Group A/S EV-to-Revenue Historical Data

The historical data trend for Pharma Equity Group A/S's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S EV-to-Revenue Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Pharma Equity Group A/S's EV-to-Revenue

For the Biotechnology subindustry, Pharma Equity Group A/S's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Equity Group A/S's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group A/S's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group A/S's EV-to-Revenue falls into.

Pharma Equity Group A/S EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pharma Equity Group A/S's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	305.019	/	0
	=

Pharma Equity Group A/S's current Enterprise Value is kr305.02 Mil.
Pharma Equity Group A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Pharma Equity Group A/S (OCSE:PEG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pharma Equity Group A/S's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.262	/	0
	=

Pharma Equity Group A/S's share price for today is kr0.262.
Pharma Equity Group A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.

Pharma Equity Group A/S EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.